U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Transient hyperphenylalaninemia

MedGen UID:
78679
Concept ID:
C0268464
Disease or Syndrome
Synonyms: Hyperphenylalaninemia, type III; Neonatal hyperphenylalaninemia; Transient mild hyperphenylalaninemia
SNOMED CT: Transient hyperphenylalaninemia (28575006); Neonatal hyperphenylalaninemia (28575006); Hyperphenylalaninemia, type III (28575006); Transient mild hyperphenylalaninemia (28575006)
 
HPO: HP:0008297

Definition

A condition of not having consistently high levels of phenylalanine in the blood but of experiencing temporary hyperphenylalaninemia following ingestion of large quantities of phenylalanine (for instance, following an oral loading test with phenylalanine). [from HPO]

Conditions with this feature

Dopa-responsive dystonia due to sepiapterin reductase deficiency
MedGen UID:
120642
Concept ID:
C0268468
Disease or Syndrome
The phenotypic spectrum of sepiapterin reductase deficiency (SRD), which ranges from significant motor and cognitive deficits to only minimal findings, has not been completely elucidated. Clinical features in the majority of affected individuals include motor and speech delay, axial hypotonia, dystonia, weakness, and oculogyric crises; symptoms show diurnal fluctuation and sleep benefit. Other common features include parkinsonian signs (tremor, bradykinesia, masked facies, rigidity), limb hypertonia, hyperreflexia, intellectual disability, psychiatric and/or behavioral abnormalities, autonomic dysfunction, and sleep disturbances (hypersomnolence, difficulty initiating or maintaining sleep, and drowsiness). Most affected individuals have nonspecific features in infancy including developmental delays and axial hypotonia; other features develop over time.
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency
MedGen UID:
337890
Concept ID:
C1849700
Disease or Syndrome
Tetrahydrobiopterin (BH4)-deficient hyperphenylalaninemia (HPA) D is an autosomal recessive disorder characterized by mild transient hyperphenylalaninemia often detected by newborn screening. Patients also show increased excretion of 7-biopterin. Affected individuals are asymptomatic and show normal psychomotor development, although transient neurologic deficits in infancy have been reported (Thony et al., 1998). Patients may also develop hypomagnesemia and nonautoimmune diabetes mellitus during puberty (summary by Ferre et al., 2014). For a general phenotypic description and a discussion of genetic heterogeneity of BH4-deficient hyperphenylalaninemia, see HPABH4A (261640).
Dystonia 5
MedGen UID:
342121
Concept ID:
C1851920
Disease or Syndrome
GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep). Initial symptoms are often gait difficulties attributable to flexion-inversion (equinovarus posture) of the foot. Occasionally, initial symptoms are arm dystonia, postural tremor of the hand, or slowness of movements. Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal toe (dystonic extension of the big toe) are present in many affected individuals. In general, gradual progression to generalized dystonia is observed. Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur.

Professional guidelines

PubMed

Ismail SR, Abdel-Rahim N, Hashishe MM, Abdallah EM
J Egypt Public Health Assoc 1996;71(5-6):495-520. PMID: 17214193

Recent clinical studies

Etiology

Ismail SR, Abdel-Rahim N, Hashishe MM, Abdallah EM
J Egypt Public Health Assoc 1996;71(5-6):495-520. PMID: 17214193

Diagnosis

Ross LF, Paul DB
J Pediatr 2018 Apr;195:65. doi: 10.1016/j.jpeds.2017.10.001. PMID: 29576183
Ismail SR, Abdel-Rahim N, Hashishe MM, Abdallah EM
J Egypt Public Health Assoc 1996;71(5-6):495-520. PMID: 17214193
Dhondt JL
J Pediatr 1984 Apr;104(4):501-8. doi: 10.1016/s0022-3476(84)80537-5. PMID: 6142937
Castells S, LaCamera RG, Wessel MA, Brandt IK
J Pediatr 1968 Apr;72(4):530-3. doi: 10.1016/s0022-3476(68)80345-2. PMID: 5647296

Therapy

Ismail SR, Abdel-Rahim N, Hashishe MM, Abdallah EM
J Egypt Public Health Assoc 1996;71(5-6):495-520. PMID: 17214193
Dhondt JL
J Pediatr 1984 Apr;104(4):501-8. doi: 10.1016/s0022-3476(84)80537-5. PMID: 6142937
Watkins ML, Crump EP, Hara S
J Natl Med Assoc 1971 Jul;63(4):241-5. PMID: 4946844Free PMC Article

Prognosis

Ismail SR, Abdel-Rahim N, Hashishe MM, Abdallah EM
J Egypt Public Health Assoc 1996;71(5-6):495-520. PMID: 17214193

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...